Schnoll-Sussman Felice, Katz Philip O
Department of Gastroenterology & Hepatology, Jay Monahan Center for Gastrointestinal Health, Weill Cornell Medicine, New York, NY, USA.
Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Curr Treat Options Gastroenterol. 2016 Sep;14(3):315-26. doi: 10.1007/s11938-016-0102-2.
Esophageal dysphagia in the elderly is a common clinical problem. Achalasia is a disease in which there is loss of ganglion in the myenteric plexus of the lower esophageal sphincter resulting in incomplete relaxation of that muscle causing a functional obstruction to outflow. Treatment is aimed at reducing sphincter pressure allowing for gravity and the oral portion of the swallow to propel the bolus through the esophagus. Pneumatic dilatation, Heller myotomy (laparoscopic), and the newest procedure peroral endoscopic esophageal myotomy (POEM) are all reasonable options for effective treatment even in the elderly. The choice depends on the decision of the patient, subtype of achalasia, local expertise, and fitness for surgery. Patients over 45 with type 2 achalasia respond exceptionally well to pneumatic dilation, and we recommend consideration of this technique if expertise is available. POEM has achieved excellent short-term results and if local expertise exists, it should be strongly considered especially in patients with type 3 achalasia. Type 1 achalasia may respond slightly better to myotomy, either Heller or POEM. Proton pump inhibitors remain the treatment of choice for GERD and should not be avoided in the elderly for fear of adverse reactions. While none of the FDA warnings nor concern for chronic renal failure or dementia can be dismissed, much more research is needed before we accept that PPIs are truly causal. Surgery for GERD in patients over 65 is as effective as in the young and should be considered in appropriate candidates. Eosinophilic esophagitis, while not common in the elderly, frequently results in clinically important dysphagia. PPIs, topical oral steroids, and dietary interventions are all used individually and together to improve symptoms. PPIs remain first line and are required twice daily for at least 8 weeks as an initial trial. Dilation with either balloons or polyvinyl dilators are highly effective in patients with rings and focal strictures, can be performed safely, and limit the number of medications an elderly patient needs to take.
老年人食管吞咽困难是一个常见的临床问题。贲门失弛缓症是一种在下食管括约肌肌间神经丛中神经节缺失的疾病,导致该肌肉不能完全松弛,从而造成功能性流出道梗阻。治疗旨在降低括约肌压力,借助重力和吞咽的口腔部分动作推动食团通过食管。气囊扩张术、Heller肌切开术(腹腔镜)以及最新的经口内镜下食管肌切开术(POEM)都是有效的治疗选择,即使对于老年人也是如此。选择取决于患者的决定、贲门失弛缓症的亚型、当地的专业技术以及手术适应性。45岁以上的2型贲门失弛缓症患者对气囊扩张术反应特别好,如果有专业技术,我们建议考虑采用这种技术。POEM已取得出色的短期效果,如果当地有专业技术,应强烈考虑,尤其是对于3型贲门失弛缓症患者。1型贲门失弛缓症对肌切开术(Heller或POEM)的反应可能稍好一些。质子泵抑制剂仍然是治疗胃食管反流病(GERD)的首选药物,不应因担心不良反应而在老年人中避免使用。虽然美国食品药品监督管理局(FDA)的警告以及对慢性肾衰竭或痴呆症的担忧都不能忽视,但在我们认定质子泵抑制剂是真正的病因之前,还需要更多的研究。65岁以上患者的GERD手术治疗效果与年轻人一样好,合适的患者应考虑手术。嗜酸性粒细胞性食管炎在老年人中虽不常见,但常导致具有临床重要性的吞咽困难。质子泵抑制剂、局部口服类固醇和饮食干预都可单独或联合使用以改善症状。质子泵抑制剂仍然是一线治疗药物,作为初始试验需要每天服用两次,至少服用8周。使用球囊或聚乙烯扩张器进行扩张对有环和局灶性狭窄的患者非常有效,可以安全进行,并且可以减少老年患者需要服用的药物数量。